Cerevel Therapeutics Holdings, Inc.
NASDAQ:CERE
44.96 (USD) • At close July 31, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | 2014 Q4 | 2014 Q3 | 2014 Q2 | 2014 Q1 | 2013 Q4 | 2013 Q3 | 2013 Q2 | 2013 Q1 | 2012 Q4 | 2012 Q3 | 2012 Q2 | 2012 Q1 | 2000 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 8.246 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.415 | 0.351 | 0.942 | 0.852 | 1.125 | 0.343 | 0.4 | 0.34 | 0.806 | 0.495 | 0.763 | 0.897 | 1.355 | 1.025 | 1.966 | 1.164 | 1.148 | -3.691 | 0 |
| Cost of Revenue
| 1.541 | 1.504 | 1.449 | 1.353 | 1.321 | 1.295 | 1.267 | 1.223 | 1.118 | 1.644 | 0.98 | 0.601 | 0.063 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.538 | 0.787 | 0.946 | 1.831 | 0.86 | 2.134 | 0.442 | 0.581 | 0.575 | 0.556 | 1.309 | 1.131 | 2.134 | 2.28 | 0.7 | 0.508 | 0.627 | 1.816 | 0 |
| Gross Profit
| -1.541 | 6.742 | -1.449 | -1.353 | -1.321 | -1.295 | -1.267 | -1.223 | -1.118 | -1.644 | -0.98 | -0.601 | -0.063 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.877 | -0.436 | -0.004 | -0.979 | 0.265 | -1.791 | -0.042 | -0.241 | 0.231 | -0.061 | -0.546 | -0.234 | -0.779 | -1.255 | 1.266 | 0.656 | 0.521 | -5.507 | 0 |
| Gross Profit Ratio
| 0 | 0.818 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.62 | -1.242 | -0.004 | -1.149 | 0.236 | -5.222 | -0.105 | -0.709 | 0.287 | -0.123 | -0.716 | -0.261 | -0.575 | -1.224 | 0.644 | 0.564 | 0.454 | 1.492 | 0 |
| Reseach & Development Expenses
| 106.425 | 97.127 | 85.252 | 74.081 | 78.181 | 81.312 | 71.385 | 72.539 | 55.023 | 47.841 | 40.159 | 37.294 | 36.561 | 30.135 | 24.026 | 22.183 | 26.959 | 21.968 | 17.342 | 7.008 | 3.976 | 1.113 | 1.457 | 1.718 | 2.215 | 2.516 | 2.449 | 2.504 | 2.577 | 3.595 | 3.57 | 4.414 | 3.617 | 4.073 | 4.368 | 4.343 | 3.633 | 5.255 | -1.497 | 37.294 |
| General & Administrative Expenses
| 36.231 | 42.437 | 26.055 | 22.762 | 21.37 | 25.935 | 23.68 | 20.467 | 17.507 | 16.649 | 14.368 | 13.216 | 14.01 | 11.761 | 10.336 | 12.973 | 10.743 | 14.429 | 9.643 | 5.318 | 3.779 | 2.005 | 1.413 | 2.088 | 4.997 | 3.639 | 3.869 | 3.441 | 3.752 | 3.887 | 3.585 | 3.26 | 3.487 | 4.464 | 3.392 | 3.844 | 3.672 | 3.344 | -3.021 | 13.216 |
| Selling & Marketing Expenses
| 0 | -1.504 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.831 | 0.86 | 0 | 0 | 0.117 | 1.039 | 0.556 | 1.309 | 1.131 | 0 | 0 | 0 | 0 | 0 | -1.484 | 0 |
| SG&A
| 36.231 | 40.933 | 26.055 | 22.762 | 21.37 | 25.935 | 23.68 | 20.467 | 17.507 | 16.649 | 14.368 | 13.216 | 14.01 | 11.761 | 10.336 | 12.973 | 10.743 | 14.429 | 9.643 | 5.318 | 3.779 | 2.005 | 1.413 | 2.088 | 6.828 | 4.499 | 3.869 | 3.441 | 3.869 | 4.926 | 4.141 | 4.569 | 4.618 | 4.464 | 3.392 | 3.844 | 3.672 | 3.344 | -4.505 | 13.216 |
| Other Expenses
| -0.921 | -5.339 | 7.822 | -9.765 | -11.09 | 8.648 | 0.021 | 0.008 | 0.001 | 5.316 | -7.545 | -2.739 | -0.425 | 8.702 | -4.684 | 8.418 | -15.71 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.605 | 0 |
| Operating Expenses
| 142.656 | 138.06 | 111.307 | 96.843 | 99.551 | 107.247 | 95.065 | 93.006 | 72.53 | 64.49 | 54.527 | 50.51 | 50.571 | 41.896 | 34.362 | 35.156 | 37.702 | 56.407 | 35.965 | 6.287 | 31.237 | 3.118 | 2.87 | 3.806 | 9.043 | 7.015 | 6.318 | 5.945 | 6.446 | 8.521 | 7.711 | 8.983 | 8.235 | 8.537 | 7.76 | 8.187 | 7.305 | 8.599 | -7.608 | 50.51 |
| Operating Income
| -142.656 | -139.564 | -111.307 | -96.843 | -99.551 | -107.247 | -95.065 | -93.006 | -72.53 | -64.49 | -54.527 | -50.51 | -50.571 | -41.896 | -34.362 | -35.156 | -37.702 | -36.397 | -26.985 | -12.326 | -7.755 | -2.241 | -3.306 | -3.81 | -8.191 | -5.89 | -8.109 | -5.987 | -6.106 | -7.715 | -7.216 | -8.22 | 25.252 | -9.316 | -9.015 | -6.921 | -6.649 | -8.078 | 2.062 | -50.51 |
| Operating Income Ratio
| 0 | -16.925 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.584 | -9.419 | -4.045 | -9.614 | -5.236 | -23.641 | -14.968 | -17.959 | -9.572 | -14.578 | -10.773 | 28.152 | -6.875 | -8.795 | -3.52 | -5.712 | -7.037 | -0.559 | 0 |
| Total Other Income Expenses Net
| -0.921 | 7.092 | 7.822 | -9.765 | -4.65 | 14.599 | -4.873 | 1.868 | 4.236 | 5.316 | -7.545 | -2.739 | -0.425 | 8.702 | -4.684 | 8.418 | -15.71 | -19.818 | -8.612 | 6.514 | -22.965 | 0.736 | 2.254 | 0.392 | 0.017 | -0.012 | 0.002 | 0.015 | -0.058 | -0.012 | -0.009 | 0.016 | -0.071 | -0.006 | 0.049 | 0.028 | 0.029 | -0.338 | -0.443 | -2.729 |
| Income Before Tax
| -131.774 | -132.472 | -96.238 | -99.428 | -104.201 | -92.648 | -99.938 | -90.471 | -68.294 | -59.055 | -62.059 | -53.239 | -50.981 | -33.18 | -39.045 | -26.733 | -53.208 | -56.215 | -35.597 | -5.812 | -30.72 | -1.505 | -1.052 | -3.418 | -8.174 | -5.902 | -8.107 | -5.972 | -6.164 | -7.727 | -7.225 | -8.204 | 25.181 | -9.322 | -8.966 | -6.893 | -6.62 | -8.416 | 1.619 | -53.239 |
| Income Before Tax Ratio
| 0 | -16.065 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.064 | -2.997 | -3.628 | -9.594 | -5.246 | -23.636 | -14.93 | -18.129 | -9.587 | -14.596 | -10.752 | 28.072 | -6.88 | -8.747 | -3.506 | -5.687 | -7.331 | -0.439 | 0 |
| Income Tax Expense
| 0.138 | 0.188 | 0.123 | 0.107 | 0.085 | 0.16 | 4.873 | 0.008 | -4.236 | 0.119 | -0.013 | -0.01 | -0.015 | -0.003 | -0.005 | -0.016 | -0.204 | 0.045 | 0 | 0 | 0 | 0.738 | 2.253 | 0.001 | 0.015 | 0.008 | 0.011 | 0.001 | -0.034 | -0.012 | -0.009 | -0.001 | -0.001 | 0.028 | 0.049 | 0.001 | 0.002 | 0.003 | -0.279 | 0 |
| Net Income
| -131.912 | -132.66 | -96.361 | -99.535 | -104.286 | -92.808 | -104.811 | -90.471 | -64.058 | -59.055 | -62.059 | -53.239 | -50.981 | -33.177 | -39.04 | -26.717 | -53.208 | -56.26 | -35.597 | -5.812 | -30.72 | -1.505 | -1.052 | -3.419 | -8.174 | -5.902 | -8.107 | -5.973 | -6.164 | -7.727 | -7.225 | -8.205 | 25.182 | -9.322 | -8.966 | -6.894 | -6.622 | -8.416 | 1.701 | -53.239 |
| Net Income Ratio
| 0 | -16.088 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.064 | -2.997 | -3.63 | -9.594 | -5.246 | -23.636 | -14.933 | -18.129 | -9.587 | -14.596 | -10.754 | 28.074 | -6.88 | -8.747 | -3.507 | -5.689 | -7.331 | -0.461 | 0 |
| EPS
| -0.73 | -0.76 | -0.61 | -0.63 | -0.67 | -0.59 | -0.69 | -0.61 | -0.43 | -0.4 | -0.43 | -0.42 | -0.4 | -0.3 | -0.31 | -0.21 | -0.42 | -0.35 | -7.73 | -1.26 | -6.67 | -0.11 | -0.074 | -0.24 | -0.57 | -0.41 | -0.57 | -0.42 | -0.43 | -0.31 | -0.29 | -0.33 | 1.02 | -0.65 | -0.63 | -0.48 | -0.47 | -0.59 | 0.12 | -0 |
| EPS Diluted
| -0.73 | -0.76 | -0.61 | -0.63 | -0.67 | -0.59 | -0.69 | -0.61 | -0.43 | -0.4 | -0.43 | -0.42 | -0.4 | -0.3 | -0.31 | -0.21 | -0.42 | -0.35 | -7.73 | -1.26 | -6.67 | -0.11 | -0.074 | -0.39 | -1.33 | -0.98 | -1.34 | -0.12 | -0.17 | -0.31 | -0.29 | -0.33 | 1.02 | -0.38 | -0.36 | -0.28 | -0.47 | -0.86 | 0.17 | -0 |
| EBITDA
| -127.581 | -138.06 | -93.594 | -96.788 | -99.551 | -107.247 | -89.785 | -91.108 | -75.352 | -64.49 | -53.547 | -49.909 | -50.508 | -41.896 | -34.362 | -34.966 | -37.607 | -36.387 | -26.904 | -12.266 | -7.729 | -1.408 | -0.956 | -3.299 | -8.024 | -5.729 | -7.981 | -5.843 | -5.814 | -7.345 | -6.83 | -7.792 | 24.185 | -8.965 | -8.662 | -6.558 | -6.144 | -7.569 | -1.274 | -50.51 |
| EBITDA Ratio
| 0 | -16.743 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.995 | -2.724 | -3.502 | -9.418 | -5.092 | -23.268 | -14.608 | -17.1 | -9.113 | -13.798 | -10.212 | 26.962 | -6.616 | -8.451 | -3.336 | -5.278 | -6.593 | 0.345 | 0 |